Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/01/2014 | US8765470 Reprogramming immortalized B-cells to induced pluripotent stem cells |
07/01/2014 | US8765466 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
07/01/2014 | US8765463 Chimeric adenoviruses for use in cancer treatment |
07/01/2014 | US8765462 IL-12 immunotherapy for cancer |
07/01/2014 | US8765461 HIV antisense proteins |
07/01/2014 | US8765448 Methods and means for exact replacement of target DNA in eukaryotic organisms |
07/01/2014 | US8765446 Recombinant mutant microorganisms having increased ability to produce alcohols and method of producing alcohols using the same |
07/01/2014 | US8765440 CBH1 homologs and varian CBH1 cellulase |
07/01/2014 | US8765438 Polypeptides with xylanase activity |
07/01/2014 | US8765436 DNA polymerases with increased 3′-mismatch discrimination |
07/01/2014 | US8765435 DNA polymerases with increased 3′-mismatch discrimination |
07/01/2014 | US8765434 Polynucleotide encoding a maltotriosyl transferase |
07/01/2014 | US8765426 Pantothenic acid biosynthesis in zymomonas |
07/01/2014 | US8765423 Diacylglycerol acyltransferase genes and use thereof |
07/01/2014 | US8765413 Cell cultivation process |
07/01/2014 | US8765404 Microbial engineering for the production of fatty acids and fatty acid derivatives |
07/01/2014 | US8765380 Bead emulsion nucleic acid amplification |
07/01/2014 | US8765376 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator |
07/01/2014 | US8765374 Methods for nucleic acid manipulation |
07/01/2014 | US8765143 Fusion proteins and use thereof for preparing hepatitis C vaccines |
07/01/2014 | US8765141 Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host |
07/01/2014 | US8765139 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
07/01/2014 | US8765120 Muscle-derived cells (MDCS) for augmenting or bulking urethral sphincter-muscle tissue |
07/01/2014 | US8765115 Method of treatment of gastrointestinal disorders with IL-10 |
06/26/2014 | WO2014100799A2 Cyanobacterium sp. for production of compounds |
06/26/2014 | WO2014100798A1 Novel shuttle vector capable of transforming multiple genera of cyanobacteria |
06/26/2014 | WO2014100752A1 Ergothioneine production through metabolic engineering |
06/26/2014 | WO2014100742A2 Modulation of expression of acyltransferases to modify hydroxycinnamic acid content |
06/26/2014 | WO2014100714A1 Improved exon skipping compositions for treating muscular dystrophy |
06/26/2014 | WO2014100612A1 Methods for producing heterologous polypeptides in mutants of trichoderma |
06/26/2014 | WO2014100602A1 Treatment of egf-receptor dependent pathologies |
06/26/2014 | WO2014100578A1 Peptides useful for modulating histone demethylase function |
06/26/2014 | WO2014100526A1 Improvement of ethanol yield with reduction of biomass accumulation in the recombinant strain of saccharomyces cerevisiae overexpressing alkaline phosphatase |
06/26/2014 | WO2014100525A2 Compositions and methods for auxin-analog conjugation |
06/26/2014 | WO2014100467A1 Methods for elevating fat/oil content in plants |
06/26/2014 | WO2014100406A1 Improved split seed soybean transformation for efficient and high-throughput transgenic event production |
06/26/2014 | WO2014100400A1 Compositions and methods for creating altered and improved cells and organisms |
06/26/2014 | WO2014100361A1 Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthase |
06/26/2014 | WO2014100346A1 Genetic loci associated with soybean cyst nematode resistance and methods of use |
06/26/2014 | WO2014100289A1 Transcriptional regulation for improved plant productivity |
06/26/2014 | WO2014100251A1 A cytochrome p450-based biodesulfurization pathway |
06/26/2014 | WO2014100234A1 Improved soybean transformation for efficient and high-throughput transgenic event production |
06/26/2014 | WO2014100229A1 Genetic loci associated with soybean cyst nematode resistance and methods of use |
06/26/2014 | WO2014100216A1 Cancer-Associated MicroRNAs and Related Antibodies |
06/26/2014 | WO2014100073A2 Expression vectors for recombinant protein production in mammalian cells |
06/26/2014 | WO2014100061A1 Down-regulation of a polynucleotide encoding a sou2 sorbitol utilization protein to modify lipid production in microbial cells |
06/26/2014 | WO2014100050A1 Identification of a 5-gene expression signature predicting clinical outcome of patients with brain tumors |
06/26/2014 | WO2014100009A2 Plant regulatory elements and uses thereof |
06/26/2014 | WO2014099999A1 Methods for improving cardiac contractility |
06/26/2014 | WO2014099997A1 Compositions and methods that utilize a peptide tag that binds to hyaluronan |
06/26/2014 | WO2014099950A1 Gene silencing |
06/26/2014 | WO2014099908A1 Methods for inhibiting viral infection in transplant patients |
06/26/2014 | WO2014099850A1 FACTOR IXa 318R/A MUTANT |
06/26/2014 | WO2014099744A1 Rna-guided human genome engineering |
06/26/2014 | WO2014099730A1 Engineered biocatalysts and methods for synthesizing chiral amines |
06/26/2014 | WO2014099700A1 Uv-resistant microbes and uv-blocking microbial extract |
06/26/2014 | WO2014099653A1 Alpha-amylases and polynucleotides encoding same |
06/26/2014 | WO2014099632A1 Pmt2, och1, pmt5 mutant cells |
06/26/2014 | WO2014099121A1 Formulations for nucleic acid stabilization on solid substrates |
06/26/2014 | WO2014098773A1 Site-specific induction of bimolecular quadruplex-duplex hybrids and methods of using the same |
06/26/2014 | WO2014098767A1 Programmable synthetic lysis system for controlled release of macromolecules |
06/26/2014 | WO2014098649A1 Compositions and methods using toll-like receptor 5 and toll-like receptor agonist |
06/26/2014 | WO2014098453A1 Method for producing d-chiro inositol using resting cell conversion method |
06/26/2014 | WO2014098319A1 T-cell-specific humanized single fragment antibody delivery vehicle |
06/26/2014 | WO2014098249A1 Composition having tissue repairing activity and utilization thereof |
06/26/2014 | WO2014098210A1 Apoptosis-inducing agent |
06/26/2014 | WO2014098188A1 METHOD FOR PRODUCING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID DERIVATIVE, AND METHOD FOR PURIFYING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID |
06/26/2014 | WO2014098112A1 Modified lectin derived from wisteria floribunda |
06/26/2014 | WO2014098098A1 Heterocyclic amide derivative, and medicine containing same |
06/26/2014 | WO2014098089A1 Method for promoting fungi growth |
06/26/2014 | WO2014098088A1 Antifungal agent |
06/26/2014 | WO2014097932A1 Marker peptide for determining risk for hyperglycemia and use thereof |
06/26/2014 | WO2014097875A1 Development of pluripotent stem cell employing novel dedifferentiation induction method |
06/26/2014 | WO2014097733A1 Method for manufacturing human epidermal cell growth factor |
06/26/2014 | WO2014097584A1 Method for determining colon cancer |
06/26/2014 | WO2014097323A1 Novel fusion tags and expression vector system for the expression of human parathyroid hormone (rhpth) |
06/26/2014 | WO2014097321A1 Development of bioprocess for production of novel cutinases from thermobifida fusca in e. coll bl21 (de3) [accession no. mtcc 5725 and accession no. mtcc 5726] |
06/26/2014 | WO2014097085A1 Herbicide-metabolizing cytochrome p450 monooxygenases |
06/26/2014 | WO2014096992A1 Acetyl transferases and their use for producing carotenoids |
06/26/2014 | WO2014096967A2 Biological systems for production of highest quality proteins |
06/26/2014 | WO2014096836A1 Animal model with a filaggrin gene promoter |
06/26/2014 | WO2014096456A1 Anthocyanins with specific properties |
06/26/2014 | WO2014096437A1 Alternative oxidase (aox) prevents smoking-associated lung damage |
06/26/2014 | WO2014096415A1 Brassica plants resistant to clubroot |
06/26/2014 | WO2014096399A1 Manipulation of hairy and split 3 (hes3) and its regulators/mediators as a new anti-cancer strategy |
06/26/2014 | WO2014096283A2 Tobacco specific nitrosamine reduction in plants |
06/26/2014 | WO2014096245A1 Method for producing a recombinant protein of interest |
06/26/2014 | WO2014096239A1 Method for producing a recombinant protein of interest |
06/26/2014 | WO2014095990A1 Method for increasing pathogen resistance in plants |
06/26/2014 | WO2014095986A1 Preparation of amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof |
06/26/2014 | WO2014095828A1 Protein purification |
06/26/2014 | WO2014094645A1 Rna interference preparation for curing hbv |
06/26/2014 | WO2014094618A1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
06/26/2014 | WO2014094579A1 Recombinant protein |
06/26/2014 | WO2014094292A1 Cotton zeaxanthin epoxidase zep-1 and coding gene and use thereof |
06/26/2014 | WO2014094122A1 Treatment of cd47+ disease cells with sirp alpha-fc fusions |
06/26/2014 | WO2014068437A3 Enhanced acyltransferase polynucleotides, polypeptides, and methods of use |
06/26/2014 | WO2014058982A3 Nuclear factor-erythroid 2 related factor 2 (nrf2) biosensors and modulators of nrf2 |
06/26/2014 | WO2014058289A3 Method for obtaiining preparations of polypeptides having phytase activity and use thereof |
06/26/2014 | WO2014055477A3 Genes controlling photoperiod sensitivity in maize and sorghum and uses thereof |